Jeff Henretig

Jeff Henretig is an accomplished executive with extensive experience in leadership roles across various sectors. Currently serving as the Chief Executive Officer of Pzaz®, a low-dose caffeinated breath spray, Jeff is also a Venture Partner at Vectors Capital, focusing on financial strategy in climate technology investments, and a Senior Advisor at EMKO Capital, guiding investment teams on consumer-facing acquisitions. Previous roles include CEO and President of Apothecanna, CFO of Lord Jones during its acquisition by Cronos Group, and Head of Finance and Operations at Verst. Jeff began their career at Goldman Sachs Asset Management and has held positions in various finance and consulting roles, underscoring a strong background in financial management and strategic development. Educational credentials include an MBA from The Wharton School and a BA in Psychology from Columbia University.